000			01516nam\a2200349\a\4500
001			57852
005			20260628114439.0
008			260628s2015 njua b 001 0 eng
020			_a9789370609648
040			_aDNLM/DLC _cDLC _dBD-DhIUB
082	0	0	_a615.19 _222 _bN5761d
100	1		_aNg, Rick.
245	1	0	_aDrugs : _bfrom discovery to approval / _cRick Ng.
250			_a3rd ed. _breprint 2025
260			_aHoboken, N.J. : _bJohn Wiley & Sons, _cc2015.
300			_axiii, 466 p. : _bill. ; _c24 cm.
504			_aIncludes bibliographical references and index.
505	0		_aDrug discovery : targets and receptors -- Drug discovery : small molecule drugs -- Drug discovery : large molecule drugs -- Drug development and preclinical studies -- Clinical trial -- Regulatory authorities -- Regulatory applications -- Good manufacturing practice : regulatory requirements -- Good manufacturing practice : drug manufacturing -- Future perspectives.
526			_aPHR _bphr _lPHAR
541			_aKarim
650		0	_aDrug development.
650	1	2	_aTechnology, Pharmaceutical.
650	2	2	_aChemistry, Pharmaceutical.
650	2	2	_aClinical Trials as Topic _xmethods.
650	2	2	_aDrug Approval _xlegislation & jurisprudence.
650	2	2	_aDrug Approval _xmethods.
650	2	2	_aDrug Design.
856	4	1	_3Table of contents only
942			_2ddc _cBK
999			_c57852 _d58026